Register      Login
Australian Journal of Primary Health Australian Journal of Primary Health Society
The issues influencing community health services and primary health care
RESEARCH ARTICLE

Upscaling HIV and hepatitis C testing in primary healthcare settings: stigma-sensitive practice

Emily Lenton A C , Jen Johnson A and Graham Brown A B
+ Author Affiliations
- Author Affiliations

A The Australian Research Centre in Sex, Health and Society, La Trobe University, Bundoora, Vic., Australia.

B Present address: Centre for Social Impact UNSW, 704, Level 7, Science Engineering Building, UNSW Sydney, NSW 2052, Australia.

C Corresponding author. Email: e.lenton@latrobe.edu.au

Australian Journal of Primary Health 27(4) 255-258 https://doi.org/10.1071/PY20176
Submitted: 17 August 2020  Accepted: 5 March 2021   Published: 22 June 2021

Abstract

Increasing testing for viral hepatitis and HIV is central to meeting World Health Organization and Australian targets to eliminate blood-borne viruses as public health priorities by 2030. In this paper we draw on findings and recommendations from a Victorian consultation with 40 health and community practitioners engaged with blood-borne virus testing. The consultation focused on identifying what constitutes best practice in pre- and post-testing discussion in the current era of highly effective treatments for HIV and hepatitis C. Overall, the consultation found that the pre- and post-test discussion remains an important feature of testing, but, given that stigma continues to impact the lives of people affected by these viruses, sensitivity to this issue needs to inform how these discussions take place. We describe how primary healthcare settings can support the goal of upscaling HIV and hepatitis C testing in a way that delivers safe and stigma-free testing encounters. We offer the notion of ‘stigma-sensitive practice’ as a term to describe this approach to pre- and post-test discussions.

Keywords: blood-borne virus testing, primary healthcare, stigma-sensitive practice.


References

Bateganya MH, Sileo KM, Wanyenze RK, Kiene SM (2016) Strategies for delivery of HIV test results in population-based HIV seroprevalence surveys: a review of the evidence. Public Health 135, 3–13.
Strategies for delivery of HIV test results in population-based HIV seroprevalence surveys: a review of the evidence.Crossref | GoogleScholarGoogle Scholar | 26947313PubMed |

Bell SA, Delpech V, Casabona J, Tsereteli N, de Wit J (2015) Delivery of HIV test results, post‐test discussion and referral in health care settings: a review of guidance for European countries. HIV Medicine 16, 620–627.
Delivery of HIV test results, post‐test discussion and referral in health care settings: a review of guidance for European countries.Crossref | GoogleScholarGoogle Scholar | 26108859PubMed |

Bell S, Casabona J, Tsereteli N, Raben D, de Wit J (2017) HIV pre-test practices: an online survey examining perceptions of informed consent and pre-test information delivery in health care settings across the WHO European Region. International Journal of STD & AIDS 28, 558–563.
HIV pre-test practices: an online survey examining perceptions of informed consent and pre-test information delivery in health care settings across the WHO European Region.Crossref | GoogleScholarGoogle Scholar |

Broady TR, Cama E, Brener L, Hopwood M, de Wit J, Treloar C (2018) Responding to a national policy need: development of a stigma indicator for bloodborne viruses and sexually transmissible infections. Australian and New Zealand Journal of Public Health 42, 513–515.
Responding to a national policy need: development of a stigma indicator for bloodborne viruses and sexually transmissible infections.Crossref | GoogleScholarGoogle Scholar | 30198593PubMed |

Commonwealth Department of Health (2018) Fifth National Hepatitis C Strategy 2018–2022. Department of Health, Canberra, ACT, Australia.

Commonwealth of Australia (2020) National Hepatitis C Testing Strategy. Commonwealth of Australia, Canberra, ACT, Australia.

De Cock KM, Johnson AM (1998) From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing. British Medical Journal 316, 290–293.
From exceptionalism to normalisation: a reappraisal of attitudes and practice around HIV testing.Crossref | GoogleScholarGoogle Scholar | 9472517PubMed |

Down I, Ellard J, Triffitt K, Brown G, Prestage G (2015) Factors associated with recent previous HIV testing among a sample of recently HIV-diagnosed gay men in Australia: a cross-sectional study. Sexually Transmitted Infections 91, 189–193.

Downing M, Knight K, Reiss TH, Vernon K, Mulia N, Ferreboeuf M, Carroll A, Vu C (2001) Drug users talk about HIV testing: motivating and deterring factors. AIDS Care 13, 561–577.
Drug users talk about HIV testing: motivating and deterring factors.Crossref | GoogleScholarGoogle Scholar | 11571004PubMed |

Easterbrook P, Johnson C, Figueroa C, Baggaley R (2016) HIV and hepatitis testing: global progress, challenges, and future directions. AIDS Reviews 18, 3–14.

Flowers P, Knussen C, Li J, McDaid L (2013) Has testing been normalized? An analysis of changes in barriers to HIV testing among men who have sex with men between 2000 and 2010 in Scotland, UK. HIV Medicine 14, 92–98.
Has testing been normalized? An analysis of changes in barriers to HIV testing among men who have sex with men between 2000 and 2010 in Scotland, UK.Crossref | GoogleScholarGoogle Scholar | 22934820PubMed |

Fraser S, Seear K (2011) Making disease, making citizens: the politics of hepatitis C. (Routledge)

Johns DM, Bayer R, Fairchild AL (2016) Evidence and the politics of deimplementation: the rise and decline of the “counseling and testing” paradigm for HIV prevention at the US Centers for Disease Control and Prevention. The Milbank Quarterly 94, 126–162.
Evidence and the politics of deimplementation: the rise and decline of the “counseling and testing” paradigm for HIV prevention at the US Centers for Disease Control and Prevention.Crossref | GoogleScholarGoogle Scholar | 26994712PubMed |

Johnson J, Lenton E (2017) HIV and hepatitis pre- and post-test discussion in Victoria: Consultation report. Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Vic, Australia.

Johnson J, Lenton E (2018a) Talking Testing Tools: Initiating Hepatitis C Testing. Available at https://www.latrobe.edu.au/__data/assets/pdf_file/0005/972239/Talking-Testing-Hepatitis-C.pdf [Verified 29 April 2021]

Johnson J, Lenton E (2018b) Talking Testing Tools: Initiating HIV Testing. Available at https://www.latrobe.edu.au/__data/assets/pdf_file/0009/972234/Talking-Testing-HIV.pdf [Verified 29 April 2021]

Jones L, Atkinson A, Bates G, McCoy E, Porcellato L, Beynon C, McVeigh J, Bellis MA (2014) Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research. The International Journal on Drug Policy 25, 204–211.
Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research.Crossref | GoogleScholarGoogle Scholar | 24332457PubMed |

Knight R, Small W, Shoveller JA (2016) HIV stigma and the experiences of young men with voluntary and routine HIV testing. Sociology of Health & Illness 38, 153–167.
HIV stigma and the experiences of young men with voluntary and routine HIV testing.Crossref | GoogleScholarGoogle Scholar |

Lazarus JV, Wiktor S, Colombo M, Thursz M (2017) Micro-elimination–a path to global elimination of hepatitis C. Journal of Hepatology 67, 665–666.
Micro-elimination–a path to global elimination of hepatitis C.Crossref | GoogleScholarGoogle Scholar | 28760329PubMed |

Leitinger D, Ryan KE, Brown G, Pedrana A, Wilkinson AL, Ryan C, Hellard M, Stoové M (2018) Acceptability and HIV prevention benefits of a peer-based model of rapid point of care HIV testing for Australian gay, bisexual and other men who have sex with men. AIDS and Behavior 22, 178–189.

Lui CW, Dean J, Mutch A, Mao L, Debattista J, Lemoire J, Howard C, Whittaker A, Fitzgerald L (2018) HIV testing in men who have sex with men: a follow-up review of the qualitative literature since 2010. AIDS and Behavior 22, 593–605.

O’Sullivan M, Jones AM, Gage H, Jordan J, MacPepple E, Williams H, Verma S (2020) ITTREAT (Integrated Community Test‐Stage‐TREAT) Hepatitis C service for people who use drugs: real‐world outcomes. Liver International 40, 1021–1031.
ITTREAT (Integrated Community Test‐Stage‐TREAT) Hepatitis C service for people who use drugs: real‐world outcomes.Crossref | GoogleScholarGoogle Scholar | 32048798PubMed |

Rhodes T, Treloar C (2008) The social production of hepatitis C risk among injecting drug users: a qualitative synthesis. Addiction 103, 1593–1603.

Seale C (1999) Quality in qualitative research. Qualitative Inquiry 5, 465–478.
Quality in qualitative research.Crossref | GoogleScholarGoogle Scholar |

Treloar C, Rance J, Backmund M (2013) Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clinical Infectious Diseases 57, S51–S55.
Understanding barriers to hepatitis C virus care and stigmatization from a social perspective.Crossref | GoogleScholarGoogle Scholar | 23884066PubMed |

United Nations General Assembly (2016) Political Declaration on HIV and AIDS: On the fast-track to accelerate the fight against HIV and to end the AIDS epidemic by 2030. United Nations, New York, NY, USA.

Wringe A, Moshabela M, Nyamukapa C, Bukenya D, Ondenge K, Ddaaki W, Wamoyi J, Seeley J, Church K, Zaba B, Hosegood V, Bonnington O, Skovdal M, Renju J (2017) HIV testing experiences and their implications for patient engagement with HIV care and treatment on the eve of ‘test and treat’: findings from a multicountry qualitative study. Sexually Transmitted Infections 93,
HIV testing experiences and their implications for patient engagement with HIV care and treatment on the eve of ‘test and treat’: findings from a multicountry qualitative study.Crossref | GoogleScholarGoogle Scholar | 28736397PubMed |